Evolution and Treatments of Chronic Inflammatory Systemic Diseases
Observational · No treatment assigned · 1 site · Centre Hospitalier Universitaire de Besancon
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Diseases, Ulcerative Colitis and Crohn Disease. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Patients treated for IBD (MC, UC or indeterminate colitis) in the gastroenterology department of Besançon University Hospital
- Subject meeting the clinical, morphological and histological diagnostic criteria for MC, UC or indeterminate colitis or
- Patients treated for chronic inflammatory rheumatism (RA, SpA, PsA) in the rheumatology department of the University Hospital of Besançon Subject meeting the ACR 2010 classification criteria of RA or modified New York criteria of…
Plus 1 more requirement(s). There are also 2 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 3000 participants are expected to take part.
- Start date: 2019-12-11.
- Main results expected around 2029-12 (estimate from the record).
- 1 study site listed (1 marked recruiting) in France.
Main thing being measured
- Diagnosis of a second inflammatory disease (through study completion (up to 10 years))
In the researchers’ words
Patients with chronic inflammatory diseases (CID) followed in gastroenterology, dermatology and rheumatology have physiopathological, epidemiological and therapeutic focal points. The pathologies concerned are inflammatory bowel diseases (IBD - Crohn's disease \[MC\] and ulcerative colitis \[RCH\]), chronic inflammatory skin diseases (psoriasis or Verneuil's disease) and chronic inflammatory rheumatic diseases…
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Diseases; Ulcerative Colitis; Crohn Disease; Arthritis, Rheumatoid; Spondyloarthritis; Psoriatic Arthritis; Psoriasis; Verneuil's Disease |
| Lead sponsor | Centre Hospitalier Universitaire de Besancon |
| Enrollment | 3000 (estimated) |
| Start date | 2019-12-11 |
| Primary completion (est.) | 2029-12 |
| First posted | 2019-12-09 |
| Last updated | 2024-11-27 |
| Official title | Evolution and Treatments of Chronic Inflammatory Systemic Diseases: Implementation of a Hospital Cohort in the Gastroenterology, Dermatology and Rheumatology Departments of the University Hospital of Besançon |
| ClinicalTrials.gov ID | NCT04191395 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Patients treated for IBD (MC, UC or indeterminate colitis) in the gastroenterology department of Besançon University Hospital * Subject meeting the clinical, morphological and histological diagnostic criteria for MC, UC or indeterminate colitis or * Patients treated for chronic inflammatory rheumatism (RA, SpA, PsA) in the rheumatology department of the University Hospital of Besançon Subject meeting the ACR 2010 classification criteria of RA or modified New York criteria of Ankylosing spondylitis or ASAS criteria of axial or peripheral SpA or CASPAR criteria of PsA or * Patients treated for chronic inflammatory skin disease (Psoriasis, Verneuil's disease) in the dermatology department of the University Hospital of Besançon Exclusion Criteria: * Opposition of the patient * Patients in emergency situation, persons deprived of their liberty, protected minors or adults.
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Besançon | Besançon | France | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.